The Peripheral Vascular Devices Market was valued at USD 10.86 billion in 2023 and is expected to grow to USD 15.69 billion by 2030, representing a compound annual growth rate (CAGR) of 5.4% during the forecast period Peripheral vascular disease (PVD) refers to a condition characterized by the narrowing or blockage of blood vessels outside the heart and brain. Typically affecting the arteries and veins supplying the legs, arms, stomach, or kidneys, PVD restricts blood flow, leading to symptoms like leg pain, numbness, or wounds that don't heal properly. The primary cause is atherosclerosis, where plaque buildup in the arteries reduces blood circulation. Risk factors include smoking, diabetes, high blood pressure, and high cholesterol. If left untreated, PVD can result in severe complications, such as tissue damage, infections, or even limb amputation. The Peripheral Vascular Devices Market has witnessed a notable surge in demand and innovation across various segments like angioplasty, valvuloplasty valve repair, congenital heart defect correction, coronary thrombectomy, and other interventional procedures. Among these segments, drug-eluting devices, including drug-eluting stents and drug-coated balloons, have emerged as pivotal trends in peripheral angioplasty.To Know About The Research Methodology :- Request Free Sample Report The innovative devices play a crucial role by delivering therapeutic agents directly to the vessel walls, effectively preventing restenosis—the re-narrowing of treated arteries after interventions. For instance, Medtronic's IN.PACT Admiral Drug-Coated Balloon is designed to deliver an anti-proliferative drug to the artery walls, significantly reducing the chances of restenosis post-angioplasty. Similarly, advancements in valvuloplasty techniques, such as transcatheter aortic valve replacement (TAVR), have gained prominence for treating valvular heart diseases non-invasively. Additionally, the Peripheral Vascular Devices Market has seen notable strides in congenital heart defect correction and coronary thrombectomy procedures, owing to advancements in device technologies and techniques. The continual evolution and adoption of these innovative devices and procedures underscore the robust growth and promising prospects of the Peripheral Vascular Devices Market as it addresses critical cardiovascular conditions while enhancing patient outcomes.
Peripheral Vascular Devices Market Dynamics:
Innovative Catheter Solutions Pioneering Diagnostics and Treatments Drives the Peripheral Vascular Devices Market The Peripheral Vascular Devices Market has experienced significant advancements in catheter-based technologies, particularly in angiography, intravascular ultrasound (IVUS) or optical coherence tomography (OCT), and guiding catheters, driven by several key factors. One of the driving forces propelling this Peripheral Vascular Devices Market is the increasing prevalence of cardiovascular diseases, prompting a demand for more precise and minimally invasive diagnostic and treatment procedures. For instance, advancements in angiography catheters, such as the Siemens Artis Q biplane system, enable clinicians to obtain high-resolution images, aiding in accurate diagnoses of vascular conditions like peripheral artery disease (PAD). Furthermore, the integration of IVUS/OCT technologies into catheters has revolutionized intravascular imaging, allowing for detailed visualization of vessel structures, plaque morphology, and stent placement. Companies like Boston Scientific with their OPTICROSS HD Imaging Catheter have introduced enhanced imaging capabilities to guide interventions effectively for Peripheral Vascular Devices Market. Additionally, guiding catheters have evolved to improve procedural success rates by providing better support and maneuverability during interventions. For instance, Cordis, a Cardinal Health company, offers guiding catheters like the ADROIT™ Guiding Catheter designed to facilitate precise navigation through complex vascular anatomy. These innovations in catheter technologies are fundamentally reshaping the landscape of peripheral vascular interventions, offering clinicians enhanced precision, reduced risks, and improved patient outcomes in diagnosing and treating various vascular conditions which drives the Peripheral Vascular Devices Market. For instance, The FDA issued updated information on July 11, 2023, regarding paclitaxel-coated devices used in treating peripheral arterial disease (PAD) to inform healthcare providers. The update clarifies that after reviewing available data, there's no evidence supporting increased mortality risk associated with these devices. It recommends discussing all PAD treatment options, continued patient monitoring after device use, ensuring optimal PAD therapy, and reporting adverse events. This update follows the FDA's previous communication and aims to reassure healthcare providers about the safety of paclitaxel-coated devices for Peripheral Vascular Devices Market trend. Underdiagnosis of Peripheral Arterial Disease Implications on Peripheral Angioplasty Techniques is Challenging for Peripheral Vascular Devices Market The Peripheral Vascular Devices Market confronts multifaceted challenges that hinder the effective diagnosis and treatment of peripheral arterial disease (PAD), impacting the utilization of peripheral angioplasty techniques. A prevailing obstacle in addressing PAD is the persistent lack of awareness among both patients and healthcare professionals. Despite numerous initiatives aimed at increasing awareness about PAD symptoms and risks, the condition remains underdiagnosed or misdiagnosed. For instance, According to MMR Analysis, highlighted that nearly 50% of patients with PAD are asymptomatic or have atypical symptoms, leading to a lack of timely diagnosis. This impedes prompt initiation of appropriate therapies and interventions, delaying effective peripheral angioplasty treatments and contributing to disease progression. Limited access to adequate healthcare facilities represents a significant barrier, particularly in geographically remote or socioeconomically disadvantaged areas. The lack of infrastructure and specialized expertise required for performing peripheral angioplasty procedures poses challenges to timely and effective therapy. For example, rural communities often face disparities in healthcare access, with fewer hospitals equipped to offer advanced peripheral vascular interventions. This disparity in access not only results in delayed diagnosis and treatment initiation but also exacerbates healthcare inequities among different demographics drives Peripheral Vascular Devices Market trend. A study conducted by the Centers for Disease Control and Prevention (CDC) found that individuals residing in rural areas are more likely to have a higher prevalence of PAD-related risk factors and less access to specialized care compared to their urban counterparts, underscoring the geographical discrepancies in healthcare access. The cost associated with peripheral angioplasty procedures serves as a formidable barrier, influencing patient access to essential treatments and devices. The cumulative expenses encompass device costs, hospital fees, and post-procedural care, rendering these interventions financially burdensome for many individuals. For instance, the overall cost of peripheral angioplasty can range significantly, and high procedural expenses could deter patients from seeking timely treatments. This financial strain disproportionately affects marginalized communities and individuals with limited resources, perpetuating disparities in healthcare access and contributing to delayed or forgone treatment. Addressing these challenges demands a comprehensive approach involving healthcare stakeholders, policymakers, and medical device manufacturers. Efforts should prioritize educational campaigns to increase awareness about PAD symptoms and risk factors among both the general public and healthcare professionals. Collaborative initiatives aimed at improving healthcare infrastructure in underserved areas and fostering telemedicine solutions could enhance access to specialized care. Additionally, exploring cost-effective strategies, such as price transparency and reimbursement reforms, could mitigate financial barriers and facilitate equitable access to peripheral vascular interventions for the Peripheral Vascular Devices Market. Revolutionizing Hemodynamic Flow Alteration Devices: Advancements and Opportunities in Peripheral Vascular Innovations The Hemodynamic Flow Alteration Device presents innovation across various sectors like Embolic Protection Devices, Chronic Total Occlusion Devices, and other Peripheral Vascular Devices including Guidewires, Vascular Closure Devices, Introducer Sheaths, and Balloon Inflation Devices. One significant opportunity lies in the continuous advancements and enhancements in technologies aimed at improving the efficacy and safety of these devices. For instance, Embolic Protection Devices have evolved to mitigate the risk of embolization during interventional procedures, safeguarding against debris entering the bloodstream. Companies like Abbott Laboratories with their Emboshield NAV6 Embolic Protection System have introduced innovative designs that enhance device deliverability and capture efficiency, thereby reducing the risk of complications during procedures like carotid artery stenting. Similarly, Chronic Total Occlusion (CTO) Devices have garnered attention due to their effectiveness in treating complex arterial blockages. Advanced technologies such as CrossBoss and Stingray systems by Boston Scientific have demonstrated improved success rates in crossing chronic total occlusions, thus presenting a promising opportunity to address previously challenging cases for Peripheral Vascular Devices Market. Peripheral Vascular Devices market including Guidewires, Vascular Closure Devices, Introducer Sheaths, and Balloon Inflation Devices has seen remarkable growth opportunities. Guidewires play a pivotal role in navigating vessels and crossing lesions during interventional procedures. Companies like Terumo Corporation have introduced high-quality guidewires such as the Glidewire family, renowned for their exceptional maneuverability and precise control, enabling smoother and more accurate navigation through complex anatomies. Vascular Closure Devices have gained traction due to their ability to provide hemostasis post-procedure, reducing patient recovery times. Medtronic's MynxGrip Vascular Closure Device exemplifies advancements in minimizing complications and improving patient comfort during peripheral vascular interventions. Moreover, Introducer Sheaths and Balloon Inflation Devices have witnessed innovations aimed at enhancing safety and efficacy for Peripheral Vascular Devices Market. For instance, Cook Medical's Flexor Parallel Rapid Exchange Introducer Sheath offers improved flexibility and trackability, facilitating smoother device delivery during interventions. For instance, on June 6, 2023, BIOTRONIK initiated the limited release of its Oscar multifunctional peripheral catheter, showcased at the Leipzig Interventional Course (LINC). The Oscar catheter, designed for stenotic segment dilation in peripheral vessels, introduces a pioneering approach in the Peripheral Vascular Devices Market. Comprising three fully user-adjustable components, including a support catheter with integrated Lock Grip, extendable dilator, and length-adjustable PTA balloon, the catheter aims to provide tailored support during access and dilation of femoral, popliteal, and infrapopliteal arteries. This innovative release aligns with the market's trend towards customizable solutions for diverse anatomical challenges in peripheral vascular interventions, marking a significant leap in addressing complex peripheral artery disease (PAD) cases.Highlighting Peripheral Vascular Devices and Their Importance:
The increasing prevalence of peripheral vascular diseases coupled with the growing aging population globally. The rising incidence of conditions like peripheral artery disease (PAD) has expanded the market potential for these devices. According to the Global Burden of Disease Study, PAD has affected over 200 million individuals worldwide. This surge in disease prevalence has created a demand for advanced peripheral vascular devices that offer minimally invasive treatment options, contributing to market growth opportunities. Furthermore, the integration of innovative materials and the development of next-generation devices with enhanced functionalities offer significant growth potential. Manufacturers are investing in materials science research to create devices with improved biocompatibility, flexibility, and durability. For instance, the incorporation of bioresorbable materials in some vascular devices aims to reduce long-term complications and enhance patient outcomes. Innovations in Embolic Protection Devices, Chronic Total Occlusion Devices, and other peripheral vascular devices underscore the potential for improved patient outcomes for Peripheral Vascular Devices Market growth in the coming years. For instance, in September 2023, the US FDA granted approval to LimFlow SA's endovascular device, the LimFlow System for Transcatheter Arterialization of Deep Veins (TADV), targeting patients with chronic limb-threatening ischemia (CLTI) at risk for major amputation, particularly those unsuitable for conventional revascularization methods. This innovative device redirects arterial flow from the leg arteries into the venous system of the affected limb, delivering oxygen-rich arterial blood. Termed TADV, this technique provides a potential solution for severely ischemic feet by supplying oxygenated blood and addressing critical limb ischemia. This FDA approval marks a significant advancement in addressing CLTI in patients who aren't candidates for traditional revascularization, potentially reducing the risk of major amputations.
Peripheral Vascular Devices Market Segment Analysis:
Based on device type, the market has been divided into Peripheral Vascular Stents, Drug-Eluting Stents, Drug Eluting Balloons, and Peripheral Vascular Bioresorbable Scaffolds. Among these, the Peripheral Vascular Stents sub-segment is projected to generate the maximum revenue. The Peripheral Vascular Stents sub-segment witnessed the highest market share in the global Peripheral Vascular Devices Market in 2022. In the domain of Peripheral Vascular Devices Market, stents represent a critical category, including self-expanding stents, balloon-expanding stents, and covered stents, each catering to distinct clinical requirements in peripheral vascular interventions. Self-expanding stents are designed with materials that possess shape-memory characteristics, allowing them to expand gradually and conform to the vessel walls without external force. These stents provide continuous support, particularly in anatomical regions with variable diameters or areas prone to movement, such as the iliac arteries. Conversely, balloon-expanding stents, also known as balloon-expandable stents, are implanted through balloon inflation. These stents offer precise deployment control, enabling accurate placement in predetermined locations. They are commonly used in more rigid vessels where exact placement is crucial, like the iliac or common femoral arteries. Covered stents, another subset, incorporate a synthetic covering to shield the stent mesh, preventing embolization or containing aneurysms. These stents find utility in treating an array of conditions, including arterial dissections or managing pseudoaneurysms. Their use extends to various anatomical sites, such as the aorta, iliac, and peripheral arteries. These factors are anticipated to boost the growth of the Peripheral Vascular Stents sub-segment during the forecast timeframe.Peripheral Vascular Devices Market Regional Insights:
In North America, the Peripheral Vascular Devices Market stands as a critical domain, led by the United States as the largest producing and consuming region. The region showcases a robust manufacturing ecosystem with several key players headquartered in the U.S., including Abbott Laboratories, Boston Scientific, and others. The U.S. not only serves as a significant manufacturer of peripheral vascular devices but also stands as a major consumer, driven by the high prevalence of peripheral artery disease (PAD) and other vascular conditions. In terms of regional import-export dynamics, while the U.S. primarily focuses on domestic production to meet local demand, it also engages in both imports and exports of peripheral vascular devices. The U.S. imports specialized devices and components from various global markets to supplement its domestic supply chain. Simultaneously, it exports a considerable volume of peripheral vascular devices to cater to international Peripheral Vascular Devices Market demands, often exporting to regions in Europe, Asia-Pacific, and other parts of the world. This trade balance reflects the U.S.'s significant influence on the global Peripheral Vascular Devices Market, positioning it as a pivotal hub for both production and consumption, and highlighting its role in shaping the Peripheral Vascular Devices Market.Peripheral Vascular Devices Market Scope: Inquiry Before Buying
Global Peripheral Vascular Devices Market Report Coverage Details Base Year: 2023 Forecast Period: 2024-2030 Historical Data: 2018 to 2023 Market Size in 2023: US $ 10.86 Bn. Forecast Period 2024 to 2030 CAGR: 5.4% Market Size in 2030: US $ 15.69 Bn. Segments Covered: by Device Type Peripheral Vascular Stents Self-Expanding Stents Balloon Expanding Stents Covered Stents Drug-Eluting Stents Drug Eluting Balloons Peripheral Vascular Bioresorbable Scaffolds by Indication Target Artery Instability (TAI) Access Artery Injury (AAI) Peripheral Arterial Disease Arteriovenous Fistulas Peripheral Aneurysms Others by Artery Carotid Artery Fem-Pop Artery lliac Artery Infrapop Artery by End-User Hospitals Ambulatory Surgical Centers/Outpatients Cardiac Catheterization Labs Peripheral Vascular Devices Market by Region:
North America (United States, Canada, and Mexico) Europe (UK, France, Germany, Italy, Spain, Sweden, Austria, and the Rest of Europe) Asia Pacific (China, South Korea, Japan, India, Australia, Indonesia, Malaysia, Vietnam, Taiwan, Bangladesh, Pakistan, and the Rest of APAC) Middle East and Africa (South Africa, GCC, Egypt, Nigeria, and the Rest of ME&A) South America (Brazil, Argentina Rest of South America)Peripheral Vascular Devices Market Leading Key Players
North America 1. Abbott Laboratories (USA) 2. Boston Scientific Corporation (USA) 3. Cook Medical Incorporated (USA) 4. Cardinal Health, Inc. (USA) 5. Cordis Corporation (USA) 6. Penumbra, Inc. (USA) 7. Johnson & Johnson (USA) 8. AngioDynamics, Inc. (USA) 9. Endologix, Inc. (USA) 10. Teleflex Incorporated (USA) 11. C.R. Bard, Inc. (USA) 12. Edwards Lifesciences Corporation (USA) 13. Merit Medical Systems, Inc. (USA) Europe: 1. Medtronic plc (Ireland) 2. B. Braun Melsungen AG (Germany) 3. Biotronik SE & Co. KG (Germany) 4. Lombard Medical Technologies (United Kingdom) 5. Jotec GmbH (Germany) Asia Pacific: 1. Terumo Corporation (Japan) 2. Asahi Intecc Co., Ltd. (Japan) FAQ: 1] What segments are covered in the Global Peripheral Vascular Devices Market report? Ans. The segments covered in the Peripheral Vascular Devices Market report are based on Device Type, Indication, Artery, and End User. 2] Which region is expected to hold the highest share in the Global Peripheral Vascular Devices Market? Ans. The North American region is expected to hold the highest share in the Peripheral Vascular Devices Market. 3] What is the market size of the Global Peripheral Vascular Devices Market by 2030? Ans. The market size of the Peripheral Vascular Devices Market by 2030 is expected to reach USD 15.69 Billion 4] Who are the top key players in the Peripheral Vascular Devices Market? Ans. Medtronic plc (Ireland), Abbott Laboratories (USA), and Boston Scientific Corporation (USA) are the top key players in the Peripheral Vascular Devices Market. 5] What was the market size of the Global Peripheral Vascular Devices Market in 2023? Ans. The market size of the Peripheral Vascular Devices Market in 2023 was valued at USD 10.86 Billion.
1. Peripheral Vascular Devices Market Introduction 1.1. Study Assumption and Market Definition 1.2. Scope of the Study 1.3. Executive Summary 2. Peripheral Vascular Devices Market: Dynamics 2.1. Market Trends by Region 2.1.1. North America 2.1.2. Europe 2.1.3. Asia Pacific 2.1.4. Middle East and Africa 2.1.5. South America 2.2. Market Dynamics by Region 2.2.1. North America 2.2.1.1. Drivers 2.2.1.2. Restraints 2.2.1.3. Opportunities 2.2.1.4. Challenges 2.2.2. Europe 2.2.2.1. Drivers 2.2.2.2. Restraints 2.2.2.3. Opportunities 2.2.2.4. Challenges 2.2.3. Asia Pacific 2.2.3.1. Drivers 2.2.3.2. Restraints 2.2.3.3. Opportunities 2.2.3.4. Challenges 2.2.4. Middle East and Africa 2.2.4.1. Drivers 2.2.4.2. Restraints 2.2.4.3. Opportunities 2.2.4.4. Challenges 2.2.5. South America 2.2.5.1. Drivers 2.2.5.2. Restraints 2.2.5.3. Opportunities 2.2.5.4. Challenges 2.3. PORTER’s Five Forces Analysis 2.4. PESTLE Analysis 2.5. Regulatory Landscape by Region 2.5.1. North America 2.5.2. Europe 2.5.3. Asia Pacific 2.5.4. Middle East and Africa 2.5.5. South America 2.6. Analysis of Government Schemes and Initiatives For Plastic Recycling Industry 2.7. Key Opinion Leader Analysis 2.8. The Global Pandemic Impact on Peripheral Vascular Devices Market 3. Peripheral Vascular Devices Market: Global Market Size and Forecast by Segmentation (by Value in USD Million) (2023-2030) 3.1. Peripheral Vascular Devices Market Size and Forecast, By Device Type (2023-2030) 3.1.1. Peripheral Vascular Stents 3.1.1.1. Self-Expanding Stents 3.1.1.2. Balloon Expanding Stents 3.1.1.3. Covered Stents 3.1.2. Drug-Eluting Stents 3.1.3. Drug Eluting Balloons 3.1.4. Peripheral Vascular Bioresorbable Scaffolds 3.2. Peripheral Vascular Devices Market Size and Forecast, By Indication (2023-2030) 3.2.1. Target Artery Instability (TAI) 3.2.2. Access Artery Injury (AAI) 3.2.3. Peripheral Arterial Disease 3.2.4. Arteriovenous Fistulas 3.2.5. Peripheral Aneurysms 3.2.6. Others 3.3. Peripheral Vascular Devices Market Size and Forecast, By Artery (2023-2030) 3.3.1. Carotid Artery 3.3.2. Fem-Pop Artery 3.3.3. lliac Artery 3.3.4. Infrapop Artery 3.4. Peripheral Vascular Devices Market Size and Forecast, By End User (2023-2030) 3.4.1. Hospitals 3.4.2. Ambulatory Surgical Centers/Outpatients 3.4.3. Cardiac Catheterization Labs 3.5. Peripheral Vascular Devices Market Size and Forecast, By Region (2023-2030) 3.5.1. North America 3.5.2. Europe 3.5.3. Asia Pacific 3.5.4. Middle East and Africa 3.5.5. South America 4. North America Peripheral Vascular Devices Market Size and Forecast by Segmentation (by Value in USD Million) (2023-2030) 4.1. North America Peripheral Vascular Devices Market Size and Forecast, By Device Type (2023-2030) 4.1.1. Peripheral Vascular Stents 4.1.1.1. Self-Expanding Stents 4.1.1.2. Balloon Expanding Stents 4.1.1.3. Covered Stents 4.1.2. Drug-Eluting Stents 4.1.3. Drug Eluting Balloons 4.1.4. Peripheral Vascular Bioresorbable Scaffolds 4.2. North America Peripheral Vascular Devices Market Size and Forecast, By Indication (2023-2030) 4.2.1. Target Artery Instability (TAI) 4.2.2. Access Artery Injury (AAI) 4.2.3. Peripheral Arterial Disease 4.2.4. Arteriovenous Fistulas 4.2.5. Peripheral Aneurysms 4.2.6. Others 4.3. North America Peripheral Vascular Devices Market Size and Forecast, By Artery (2023-2030) 4.3.1. Carotid Artery 4.3.2. Fem-Pop Artery 4.3.3. lliac Artery 4.3.4. Infrapop Artery 4.4. North America Peripheral Vascular Devices Market Size and Forecast, By End User (2023-2030) 4.4.1. Hospitals 4.4.2. Ambulatory Surgical Centers/Outpatients 4.4.3. Cardiac Catheterization Labs 4.5. North America Peripheral Vascular Devices Market Size and Forecast, by Country (2023-2030) 4.5.1. United States 4.5.1.1. United States Peripheral Vascular Devices Market Size and Forecast, By Device Type (2023-2030) 4.5.1.1.1. Peripheral Vascular Stents 4.5.1.1.1.1. Self-Expanding Stents 4.5.1.1.1.2. Balloon Expanding Stents 4.5.1.1.1.3. Covered Stents 4.5.1.1.2. Drug-Eluting Stents 4.5.1.1.3. Drug Eluting Balloons 4.5.1.1.4. Peripheral Vascular Bioresorbable Scaffolds 4.5.1.2. United States Peripheral Vascular Devices Market Size and Forecast, By Indication (2023-2030) 4.5.1.2.1. Target Artery Instability (TAI) 4.5.1.2.2. Access Artery Injury (AAI) 4.5.1.2.3. Peripheral Arterial Disease 4.5.1.2.4. Arteriovenous Fistulas 4.5.1.2.5. Peripheral Aneurysms 4.5.1.2.6. Others 4.5.1.3. United States Peripheral Vascular Devices Market Size and Forecast, By Artery (2023-2030) 4.5.1.3.1. Carotid Artery 4.5.1.3.2. Fem-Pop Artery 4.5.1.3.3. lliac Artery 4.5.1.3.4. Infrapop Artery 4.5.1.4. United States Peripheral Vascular Devices Market Size and Forecast, By End User (2023-2030) 4.5.1.4.1. Hospitals 4.5.1.4.2. Ambulatory Surgical Centers/Outpatients 4.5.1.4.3. Cardiac Catheterization Labs 4.5.2. Canada 4.5.2.1. Canada Peripheral Vascular Devices Market Size and Forecast, By Device Type (2023-2030) 4.5.2.1.1. Peripheral Vascular Stents 4.5.2.1.1.1.1. Self-Expanding Stents 4.5.2.1.1.1.2. Balloon Expanding Stents 4.5.2.1.1.1.3. Covered Stents 4.5.2.1.2. Drug-Eluting Stents 4.5.2.1.3. Drug Eluting Balloons 4.5.2.1.4. Peripheral Vascular Bioresorbable Scaffolds 4.5.2.1.5. 4.5.2.2. Canada Peripheral Vascular Devices Market Size and Forecast, By Indication (2023-2030) 4.5.2.2.1. Target Artery Instability (TAI) 4.5.2.2.2. Access Artery Injury (AAI) 4.5.2.2.3. Peripheral Arterial Disease 4.5.2.2.4. Arteriovenous Fistulas 4.5.2.2.5. Peripheral Aneurysms 4.5.2.2.6. Others 4.5.2.3. Canada Peripheral Vascular Devices Market Size and Forecast, By Artery (2023-2030) 4.5.2.3.1. Carotid Artery 4.5.2.3.2. Fem-Pop Artery 4.5.2.3.3. lliac Artery 4.5.2.3.4. Infrapop Artery 4.5.2.4. Canada Peripheral Vascular Devices Market Size and Forecast, By End User (2023-2030) 4.5.2.4.1. Hospitals 4.5.2.4.2. Ambulatory Surgical Centers/Outpatients 4.5.2.4.3. Cardiac Catheterization Labs 4.5.3. Mexico 4.5.3.1. Mexico Peripheral Vascular Devices Market Size and Forecast, By Device Type (2023-2030) 4.5.3.1.1. Peripheral Vascular Stents 4.5.3.1.1.1. Self-Expanding Stents 4.5.3.1.1.2. Balloon Expanding Stents 4.5.3.1.1.3. Covered Stents 4.5.3.1.2. Drug-Eluting Stents 4.5.3.1.3. Drug Eluting Balloons 4.5.3.1.4. Peripheral Vascular Bioresorbable Scaffolds 4.5.3.2. Mexico Peripheral Vascular Devices Market Size and Forecast, By Indication (2023-2030) 4.5.3.2.1. Target Artery Instability (TAI) 4.5.3.2.2. Access Artery Injury (AAI) 4.5.3.2.3. Peripheral Arterial Disease 4.5.3.2.4. Arteriovenous Fistulas 4.5.3.2.5. Peripheral Aneurysms 4.5.3.2.6. Others 4.5.3.3. Mexico Peripheral Vascular Devices Market Size and Forecast, By Artery (2023-2030) 4.5.3.3.1. Carotid Artery 4.5.3.3.2. Fem-Pop Artery 4.5.3.3.3. lliac Artery 4.5.3.3.4. Infrapop Artery 4.5.3.4. Mexico Peripheral Vascular Devices Market Size and Forecast, By End User (2023-2030) 4.5.3.4.1. Hospitals 4.5.3.4.2. Ambulatory Surgical Centers/Outpatients 4.5.3.4.3. Cardiac Catheterization Labs 5. Europe Peripheral Vascular Devices Market Size and Forecast by Segmentation (by Value in USD Million) (2023-2030) 5.1. Europe Peripheral Vascular Devices Market Size and Forecast, By Device Type (2023-2030) 5.2. Europe Peripheral Vascular Devices Market Size and Forecast, By Indication (2023-2030) 5.3. Europe Peripheral Vascular Devices Market Size and Forecast, By Artery (2023-2030) 5.4. Europe Peripheral Vascular Devices Market Size and Forecast, By End User (2023-2030) 5.5. Europe Peripheral Vascular Devices Market Size and Forecast, by Country (2023-2030) 5.5.1. United Kingdom 5.5.1.1. United Kingdom Peripheral Vascular Devices Market Size and Forecast, By Device Type (2023-2030) 5.5.1.2. United Kingdom Peripheral Vascular Devices Market Size and Forecast, By Indication (2023-2030) 5.5.1.3. United Kingdom Peripheral Vascular Devices Market Size and Forecast, By Artery (2023-2030) 5.5.1.4. United Kingdom Peripheral Vascular Devices Market Size and Forecast, By End User (2023-2030) 5.5.2. France 5.5.2.1. France Peripheral Vascular Devices Market Size and Forecast, By Device Type (2023-2030) 5.5.2.2. France Peripheral Vascular Devices Market Size and Forecast, By Indication (2023-2030) 5.5.2.3. France Peripheral Vascular Devices Market Size and Forecast, By Artery (2023-2030) 5.5.2.4. France Peripheral Vascular Devices Market Size and Forecast, By End User (2023-2030) 5.5.3. Germany 5.5.3.1. Germany Peripheral Vascular Devices Market Size and Forecast, By Device Type (2023-2030) 5.5.3.2. Germany Peripheral Vascular Devices Market Size and Forecast, By Indication (2023-2030) 5.5.3.3. Germany Peripheral Vascular Devices Market Size and Forecast, By Artery (2023-2030) 5.5.3.4. Germany Peripheral Vascular Devices Market Size and Forecast, By End User (2023-2030) 5.5.4. Italy 5.5.4.1. Italy Peripheral Vascular Devices Market Size and Forecast, By Device Type (2023-2030) 5.5.4.2. Italy Peripheral Vascular Devices Market Size and Forecast, By Indication (2023-2030) 5.5.4.3. Italy Peripheral Vascular Devices Market Size and Forecast, By Artery (2023-2030) 5.5.4.4. Italy Peripheral Vascular Devices Market Size and Forecast, By End User (2023-2030) 5.5.5. Spain 5.5.5.1. Spain Peripheral Vascular Devices Market Size and Forecast, By Device Type (2023-2030) 5.5.5.2. Spain Peripheral Vascular Devices Market Size and Forecast, By Indication (2023-2030) 5.5.5.3. Spain Peripheral Vascular Devices Market Size and Forecast, By Artery (2023-2030) 5.5.5.4. Spain Peripheral Vascular Devices Market Size and Forecast, By End User (2023-2030) 5.5.6. Sweden 5.5.6.1. Sweden Peripheral Vascular Devices Market Size and Forecast, By Device Type (2023-2030) 5.5.6.2. Sweden Peripheral Vascular Devices Market Size and Forecast, By Indication (2023-2030) 5.5.6.3. Sweden Peripheral Vascular Devices Market Size and Forecast, By Artery (2023-2030) 5.5.6.4. Sweden Peripheral Vascular Devices Market Size and Forecast, By End User (2023-2030) 5.5.7. Austria 5.5.7.1. Austria Peripheral Vascular Devices Market Size and Forecast, By Device Type (2023-2030) 5.5.7.2. Austria Peripheral Vascular Devices Market Size and Forecast, By Indication (2023-2030) 5.5.7.3. Austria Peripheral Vascular Devices Market Size and Forecast, By Artery (2023-2030) 5.5.7.4. Austria Peripheral Vascular Devices Market Size and Forecast, By End User (2023-2030) 5.5.8. Rest of Europe 5.5.8.1. Rest of Europe Peripheral Vascular Devices Market Size and Forecast, By Device Type (2023-2030) 5.5.8.2. Rest of Europe Peripheral Vascular Devices Market Size and Forecast, By Indication (2023-2030) 5.5.8.3. Rest of Europe Peripheral Vascular Devices Market Size and Forecast, By Artery (2023-2030) 5.5.8.4. Rest of Europe Peripheral Vascular Devices Market Size and Forecast, By End User (2023-2030) 6. Asia Pacific Peripheral Vascular Devices Market Size and Forecast by Segmentation (by Value in USD Million) (2023-2030) 6.1. Asia Pacific Peripheral Vascular Devices Market Size and Forecast, By Device Type (2023-2030) 6.2. Asia Pacific Peripheral Vascular Devices Market Size and Forecast, By Indication (2023-2030) 6.3. Asia Pacific Peripheral Vascular Devices Market Size and Forecast, By Artery (2023-2030) 6.4. Asia Pacific Peripheral Vascular Devices Market Size and Forecast, By End User (2023-2030) 6.5. Asia Pacific Peripheral Vascular Devices Market Size and Forecast, by Country (2023-2030) 6.5.1. China 6.5.1.1. China Peripheral Vascular Devices Market Size and Forecast, By Device Type (2023-2030) 6.5.1.2. China Peripheral Vascular Devices Market Size and Forecast, By Indication (2023-2030) 6.5.1.3. China Peripheral Vascular Devices Market Size and Forecast, By Artery (2023-2030) 6.5.1.4. China Peripheral Vascular Devices Market Size and Forecast, By End User (2023-2030) 6.5.2. S Korea 6.5.2.1. S Korea Peripheral Vascular Devices Market Size and Forecast, By Device Type (2023-2030) 6.5.2.2. S Korea Peripheral Vascular Devices Market Size and Forecast, By Indication (2023-2030) 6.5.2.3. S Korea Peripheral Vascular Devices Market Size and Forecast, By Artery (2023-2030) 6.5.2.4. S Korea Peripheral Vascular Devices Market Size and Forecast, By End User (2023-2030) 6.5.3. Japan 6.5.3.1. Japan Peripheral Vascular Devices Market Size and Forecast, By Device Type (2023-2030) 6.5.3.2. Japan Peripheral Vascular Devices Market Size and Forecast, By Indication (2023-2030) 6.5.3.3. Japan Peripheral Vascular Devices Market Size and Forecast, By Artery (2023-2030) 6.5.3.4. Japan Peripheral Vascular Devices Market Size and Forecast, By End User (2023-2030) 6.5.4. India 6.5.4.1. India Peripheral Vascular Devices Market Size and Forecast, By Device Type (2023-2030) 6.5.4.2. India Peripheral Vascular Devices Market Size and Forecast, By Indication (2023-2030) 6.5.4.3. India Peripheral Vascular Devices Market Size and Forecast, By Artery (2023-2030) 6.5.4.4. India Peripheral Vascular Devices Market Size and Forecast, By End User (2023-2030) 6.5.5. Australia 6.5.5.1. Australia Peripheral Vascular Devices Market Size and Forecast, By Device Type (2023-2030) 6.5.5.2. Australia Peripheral Vascular Devices Market Size and Forecast, By Indication (2023-2030) 6.5.5.3. Australia Peripheral Vascular Devices Market Size and Forecast, By Artery (2023-2030) 6.5.5.4. Australia Peripheral Vascular Devices Market Size and Forecast, By End User (2023-2030) 6.5.6. Indonesia 6.5.6.1. Indonesia Peripheral Vascular Devices Market Size and Forecast, By Device Type (2023-2030) 6.5.6.2. Indonesia Peripheral Vascular Devices Market Size and Forecast, By Indication (2023-2030) 6.5.6.3. Indonesia Peripheral Vascular Devices Market Size and Forecast, By Artery (2023-2030) 6.5.6.4. Indonesia Peripheral Vascular Devices Market Size and Forecast, By End User (2023-2030) 6.5.7. Malaysia 6.5.7.1. Malaysia Peripheral Vascular Devices Market Size and Forecast, By Device Type (2023-2030) 6.5.7.2. Malaysia Peripheral Vascular Devices Market Size and Forecast, By Indication (2023-2030) 6.5.7.3. Malaysia Peripheral Vascular Devices Market Size and Forecast, By Artery (2023-2030) 6.5.7.4. Malaysia Peripheral Vascular Devices Market Size and Forecast, By End User (2023-2030) 6.5.8. Vietnam 6.5.8.1. Vietnam Peripheral Vascular Devices Market Size and Forecast, By Device Type (2023-2030) 6.5.8.2. Vietnam Peripheral Vascular Devices Market Size and Forecast, By Indication (2023-2030) 6.5.8.3. Vietnam Peripheral Vascular Devices Market Size and Forecast, By Artery (2023-2030) 6.5.8.4. Vietnam Peripheral Vascular Devices Market Size and Forecast, By End User (2023-2030) 6.5.9. Taiwan 6.5.9.1. Taiwan Peripheral Vascular Devices Market Size and Forecast, By Device Type (2023-2030) 6.5.9.2. Taiwan Peripheral Vascular Devices Market Size and Forecast, By Indication (2023-2030) 6.5.9.3. Taiwan Peripheral Vascular Devices Market Size and Forecast, By Artery (2023-2030) 6.5.9.4. Taiwan Peripheral Vascular Devices Market Size and Forecast, By End User (2023-2030) 6.5.10. Rest of Asia Pacific 6.5.10.1. Rest of Asia Pacific Peripheral Vascular Devices Market Size and Forecast, By Device Type (2023-2030) 6.5.10.2. Rest of Asia Pacific Peripheral Vascular Devices Market Size and Forecast, By Indication (2023-2030) 6.5.10.3. Rest of Asia Pacific Peripheral Vascular Devices Market Size and Forecast, By Artery (2023-2030) 6.5.10.4. Rest of Asia Pacific Peripheral Vascular Devices Market Size and Forecast, By End User (2023-2030) 7. Middle East and Africa Peripheral Vascular Devices Market Size and Forecast by Segmentation (by Value in USD Million) (2023-2030 7.1. Middle East and Africa Peripheral Vascular Devices Market Size and Forecast, By Device Type (2023-2030) 7.2. Middle East and Africa Peripheral Vascular Devices Market Size and Forecast, By Indication (2023-2030) 7.3. Middle East and Africa Peripheral Vascular Devices Market Size and Forecast, By Artery (2023-2030) 7.4. Middle East and Africa Peripheral Vascular Devices Market Size and Forecast, By End User (2023-2030) 7.5. Middle East and Africa Peripheral Vascular Devices Market Size and Forecast, by Country (2023-2030) 7.5.1. South Africa 7.5.1.1. South Africa Peripheral Vascular Devices Market Size and Forecast, By Device Type (2023-2030) 7.5.1.2. South Africa Peripheral Vascular Devices Market Size and Forecast, By Indication (2023-2030) 7.5.1.3. South Africa Peripheral Vascular Devices Market Size and Forecast, By Artery (2023-2030) 7.5.1.4. South Africa Peripheral Vascular Devices Market Size and Forecast, By End User (2023-2030) 7.5.2. GCC 7.5.2.1. GCC Peripheral Vascular Devices Market Size and Forecast, By Device Type (2023-2030) 7.5.2.2. GCC Peripheral Vascular Devices Market Size and Forecast, By Indication (2023-2030) 7.5.2.3. GCC Peripheral Vascular Devices Market Size and Forecast, By Artery (2023-2030) 7.5.2.4. GCC Peripheral Vascular Devices Market Size and Forecast, By End User (2023-2030) 7.5.3. Nigeria 7.5.3.1. Nigeria Peripheral Vascular Devices Market Size and Forecast, By Device Type (2023-2030) 7.5.3.2. Nigeria Peripheral Vascular Devices Market Size and Forecast, By Indication (2023-2030) 7.5.3.3. Nigeria Peripheral Vascular Devices Market Size and Forecast, By Artery (2023-2030) 7.5.3.4. Nigeria Peripheral Vascular Devices Market Size and Forecast, By End User (2023-2030) 7.5.4. Rest of ME&A 7.5.4.1. Rest of ME&A Peripheral Vascular Devices Market Size and Forecast, By Device Type (2023-2030) 7.5.4.2. Rest of ME&A Peripheral Vascular Devices Market Size and Forecast, By Indication (2023-2030) 7.5.4.3. Rest of ME&A Peripheral Vascular Devices Market Size and Forecast, By Artery (2023-2030) 7.5.4.4. Rest of ME&A Peripheral Vascular Devices Market Size and Forecast, By End User (2023-2030) 8. South America Peripheral Vascular Devices Market Size and Forecast by Segmentation (by Value in USD Million) (2023-2030 8.1. South America Peripheral Vascular Devices Market Size and Forecast, By Device Type (2023-2030) 8.2. South America Peripheral Vascular Devices Market Size and Forecast, By Indication (2023-2030) 8.3. South America Peripheral Vascular Devices Market Size and Forecast, By Artery (2023-2030) 8.4. South America Peripheral Vascular Devices Market Size and Forecast, By End User (2023-2030) 8.5. South America Peripheral Vascular Devices Market Size and Forecast, by Country (2023-2030) 8.5.1. Brazil 8.5.1.1. Brazil Peripheral Vascular Devices Market Size and Forecast, By Device Type (2023-2030) 8.5.1.2. Brazil Peripheral Vascular Devices Market Size and Forecast, By Indication (2023-2030) 8.5.1.3. Brazil Peripheral Vascular Devices Market Size and Forecast, By Artery (2023-2030) 8.5.1.4. Brazil Peripheral Vascular Devices Market Size and Forecast, By End User (2023-2030) 8.5.2. Argentina 8.5.2.1. Argentina Peripheral Vascular Devices Market Size and Forecast, By Device Type (2023-2030) 8.5.2.2. Argentina Peripheral Vascular Devices Market Size and Forecast, By Indication (2023-2030) 8.5.2.3. Argentina Peripheral Vascular Devices Market Size and Forecast, By Artery (2023-2030) 8.5.2.4. Argentina Peripheral Vascular Devices Market Size and Forecast, By End User (2023-2030) 8.5.3. Rest Of South America 8.5.3.1. Rest Of South America Peripheral Vascular Devices Market Size and Forecast, By Device Type (2023-2030) 8.5.3.2. Rest Of South America Peripheral Vascular Devices Market Size and Forecast, By Indication (2023-2030) 8.5.3.3. Rest Of South America Peripheral Vascular Devices Market Size and Forecast, By Artery (2023-2030) 8.5.3.4. Rest Of South America Peripheral Vascular Devices Market Size and Forecast, By End User (2023-2030) 9. Global Peripheral Vascular Devices Market: Competitive Landscape 9.1. MMR Competition Matrix 9.2. Competitive Landscape 9.3. Key Players Benchmarking 9.3.1. Company Name 9.3.2. Service Segment 9.3.3. End Userr Segment 9.3.4. Revenue (2022) 9.3.5. Manufacturing Locations 9.4. Leading Peripheral Vascular Devices Market Companies, by Market Capitalization 9.5. Market Structure 9.5.1. Market Leaders 9.5.2. Market Followers 9.5.3. Emerging Players 9.6. Mergers and Acquisitions Details 10. Company Profile: Key Players 10.1. Medtronic plc (Ireland) 10.1.1. Company Overview 10.1.2. Business Portfolio 10.1.3. Financial Overview 10.1.4. SWOT Analysis 10.1.5. Strategic Analysis 10.1.6. Recent Developments 10.2. Abbott Laboratories (USA) 10.3. Boston Scientific Corporation (USA) 10.4. Cook Medical Incorporated (USA) 10.5. B. Braun Melsungen AG (Germany) 10.6. Terumo Corporation (Japan) 10.7. Cardinal Health, Inc. (USA) 10.8. Cordis Corporation (USA) 10.9. Biotronik SE & Co. KG (Germany) 10.10. Penumbra, Inc. (USA) 10.11. Johnson & Johnson (USA) 10.12. AngioDynamics, Inc. (USA) 10.13. Endologix, Inc. (USA) 10.14. Asahi Intecc Co., Ltd. (Japan) 10.15. Teleflex Incorporated (USA) 10.16. C.R. Bard, Inc. (USA) 10.17. Lombard Medical Technologies (United Kingdom) 10.18. Edwards Lifesciences Corporation (USA) 10.19. Merit Medical Systems, Inc. (USA) 10.20. Jotec GmbH (Germany) 11. Key Findings 12. Industry Recommendations 13. Peripheral Vascular Devices Market: Research Methodology